Information  X 
Enter a valid email address

Prairie Mining Ltd (PDZ)

  Print      Mail a friend

Friday 26 October, 2018

Prairie Mining Ltd

Application for admission of ordinary shares

RNS Number : 1918F
Prairie Mining Limited
26 October 2018
 

PRAIRIE MINING LIMITED

NEWS RELEASE  | 26 OCTOBER 2018 

 Application for admission of ordinary shares

On 30 May 2018, Prairie Mining Limited (Company) announced that 44,776,120 fully paid ordinary shares had been issued upon the conversion of a convertible loan note with a principal amount of $15,000,000, exchangeable into 44,776,120 ordinary shares (Shares) at a conversion price of $0.335 per share (Loan Note 1).

 

An application has now been made for admission of the Shares to the standard listing segment of the Official List of the FCA (Official List) and to trading on the main market of the London Stock Exchange for listed securities. The Shares, which rank pari passu with the Company's existing issued ordinary shares, are to be expected to admitted to trading (as depository interests) on 2 November 2018 (Admission). 

 

Following admission, the Company's issued ordinary share capital will continue be 212,275,089 ordinary shares.

 

The above figure of 212,275,089 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company, under the FCA's Disclosure and Transparency Rules following Admission.

For further information, contact:

Prairie Mining Limited

Tel: +44 207 478 3900

Ben Stoikovich, Chief Executive Officer

Email: [email protected]

Sapan Ghai, Head of Corporate Development

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ALSFKPDPCBDKAKB

a d v e r t i s e m e n t